Vehicle Recompete: IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR… — INDEFINITE DELIVERY / INDEFINITE QUANTITY NIHNINDS1601
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This Indefinite Delivery/Indefinite Quantity parent award supports the Pharmacology and Toxicology for Therapeutics Program under the National Institutes of Health. The vehicle, identified by solicitation NIHNINDS1601, has an ordering period that extends through September 12, 2027. It is currently classified as a full recompete and is associated with two primary awards, HHSN271201600006I and HHSN271201600007I. There are currently 18 active task orders with a total combined value of over 18.7 million dollars. SRI International is the dominant incumbent, holding 15 orders totaling approximately 17.1 million dollars, with significant funding dedicated to continuous rodent and non-rodent pharmacokinetic assessments and GLP toxicology studies. Southern Research Institute holds the remaining three orders, valued at approximately 1.66 million dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR THERAPEUTICS PROGRAM (PTTP)
2 awards under one solicitation: HHSN271201600006I, HHSN271201600007I Original Solicitation: NIHNINDS1601 Agencies: National Institutes of Health Classification: full-recompete (Confidence: high - 85/100)
Incumbents (2 companies hold orders on this vehicle): - SRI INTERNATIONAL: $17,062,450.53 across 15 orders - SOUTHERN RESEARCH INSTITUTE: $1,663,787.9 across 3 orders
Top task orders by value: - IGF::OT::IGF TASK ORDER #3, "CONTINUOUS RODENT AND NON-RODENT PHARMACOKINETIC ASSESSMENTS" ($2,910,493.4) - SRI INTERNATIONAL - SRI TO 13 - CONTINUOUS RODENT AND NON-RODENT PHARMACOKINETIC ASSESSMENTS ($2,534,574.93) - SRI INTERNATIONAL - SRI INTERNATIONAL:1110101 [20-006951] ($2,343,369.9) - SRI INTERNATIONAL - SRI INTERNATIONAL:1110101 [19-010371] ($2,241,279.02) - SRI INTERNATIONAL - SRI INTERNATIONAL:1110101[19-008791]WAGNER - GLP TOX SUITE OF STUDIES ($2,149,530) - SRI INTERNATIONAL
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes of Health
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
